Vein Wall Remodeling after Deep Vein Thrombosis: Differential Effects of Low Molecular Weight Heparin and Doxycycline

Annals of Vascular Surgery

Volumn 24, Issue 2, 2010, Pages 233-241

  Sood, Vikram ^a   Luke, Cathy ^a   Miller, Erin ^a   Mitsuya, Mayo ^a   Upchurch Jr , Gilbert R ^a   Wakefield, Thomas W ^a   Myers, Dan D ^a   Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; DOXYCYCLINE; ENOXAPARIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; LOW MOLECULAR WEIGHT HEPARIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; COLORIMETRY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; STUDENT T TEST; THROMBUS; VEIN INJURY; VEIN RECONSTRUCTION; ZYMOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; DOXYCYCLINE; ELASTICITY; ENOXAPARIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; FIBROSIS; INTERLEUKIN-1BETA; LIGATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 75149145485     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.11.002     Document Type: Article

References (39)

1. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
2. Geerts W. Antithrombotic and thrombolytic therapy. Chest 133 (2008) 381s-451s
3. Hirsh J. Oral anticoagulant drugs. N Engl J Med 324 (1991) 1865-1875
4. Meissner M.H., Caps M.T., Zierler B.K., et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 28 (1998) 826-833
5. Henke P.K., Varma M.R., Moaveni D.K., et al. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost 98 (2007) 1045-1055
6. Kahn S.R., Shrier I., Julian J.A., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149 (2008) 698-707
7. Henke P.K., Ferguson E., Varma M., Deatrick K.B., Wakefield G.T., and Woodrum D.T. Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes. J Vasc Surg 45 (2007) 998-1004 quiz 1005-1007
8. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
9. Galt S.W., Lindemann S., Medd D., et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 89 (2001) 509-516
10. Ducharme A., Frantz S., Aikawa M., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106 (2000) 55-62
11. Curci J.A., and Thompson R.W. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?. J Clin Invest 114 (2004) 168-171
12. Deatrick K.B., Eliason J.L., Lynch E.M., et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 42 (2005) 140-148
13. Henke P.K., Pearce C.G., Moaveni D.M., et al. Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol 177 (2006) 3388-3397
14. Dewyer N.A., Sood V., Lynch E.M., et al. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 142 (2007) 357-363
15. Woodside K.J., Hu M., Burke A., et al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg 38 (2003) 162-169
16. Downing L.J., Strieter R.M., Kadell A.M., Wilke C.A., Greenfield L.J., and Wakefield T.W. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 28 (1998) 848-854
17. Moaveni D.K., Lynch E.M., Luke C., et al. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg 47 (2008) 616-624
18. Myers Jr. D.D., Henke P.K., Bedard P.W., et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 44 (2006) 625-632
19. Gossage J.A., Humphries J., Modarai B., Burnand K.G., and Smith A. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. J Vasc Surg 44 (2006) 1085-1090
20. Petrinec D., Liao S., Holmes D.R., Reilly J.M., Parks W.C., and Thompson R.W. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23 (1996) 336-346
21. Sho E., Chu J., Sho M., et al. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. J Vasc Surg 39 (2004) 1312-1321
22. Pyo R., Lee J.K., Shipley J.M., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105 (2000) 1641-1649
23. Henke P.K., Varma M.R., Deatrick K.B., et al. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost 95 (2006) 272-281
24. Henke P.K., Varga A., De S., et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler. Thromb Vasc Biol 24 (2004) 1130-1137
25. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100 (2007) 158-173
26. Wakefield T.W., Strieter R.M., Wilke C.A., et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler. Thromb Vasc Biol 15 (1995) 258-268
27. Wagner D.D. New links between inflammation and thrombosis. Arterioscler. Thromb Vasc Biol 25 (2005) 1321-1324
28. Singh I., Burnand K.G., Collins M., et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 107 (2003) 869-875
29. Bouzeghrane F., Zhang X., Gevry G., and Raymond J. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice. J Vasc Surg 48 (2008) 1575-1584
30. Hogaboam C.M., Steinhauser M.L., Chensue S.W., and Kunkel S.L. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 54 (1998) 2152-2159
31. Gennaro G., Menard C., Michaud S.E., and Rivard A. Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation 107 (2003) 230-233
32. Lijnen H.R., Van Hoef B., Lupu F., Moons L., Carmeliet P., and Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb Vasc Biol 18 (1998) 1035-1045
33. Sasaki M., Kashima M., Ito T., et al. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity. Mediators Inflamm 9 (2000) 85-91
34. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
35. Wang L., Brown J.R., Varki A., and Esko J.D. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110 (2002) 127-136
36. Thanaporn P., Myers D.D., Wrobleski S.K., et al. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model. Surgery 134 (2003) 365-371
37. Aird W.C. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98 (2006) 159-162
38. Solomon A., Rosenblatt M., Li D.Q., et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest. Ophthalmol. Vis Sci 41 (2000) 2544-2557
39. Wakefield T.W., Myers D.D., and Henke P.K. Mechanisms of venous thrombosis and resolution. Arterioscler. Thromb Vasc Biol 28 (2008) 387-391